Close Menu

NEW YORK (GenomeWeb) – Guardant Health and Flatiron Health have announced a collaboration to integrate Guardant Health's liquid biopsy genomic testing results with clinical treatment and outcomes data using Flatiron's cloud-based information platform. 

The partners said this new ability to link patients' genomic data with their clinical records will hopefully support the accelerated development of targeted therapies for cancer by enabling life science companies to more quickly recruit and select patients for trials and to more easily follow subjects and their progress over time.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.